Study design/Methods: Literature review. Papers were selected from a literature search of both the Medline and Current Contents data bases and through extensive cross checking of references from the author's personal ®les. Objectives: To evaluate the evidence for a reduced level of HDL-C in individuals with spinal cord injury and to discuss physiologic and behavioral factors that may be responsible for the observed reduction, with emphasis on the role of physical activity. Results/Conclusions: The evidence presented suggests that HDL-C may be lower in persons with SCI; however, the available data should be interpreted cautiously due to lack of control for important confounding factors such as smoking, alcohol consumption and physical activity. Results suggest a potential association between increased physical activity and increased HDL-C in persons with SCI. However, the mode, frequency, intensity and duration of activity and the physiologic mechanism responsible for this association have yet to be clearly elucidated.
Introduction
The life expectancy of persons with spinal cord injury (SCI) has increased dramatically over the past 30 years. For example, the life expectancy for a person injured between 15 and 25 years of age is 54.3 years for persons with tetraplegia and 62.1 years for persons with paraplegia. 1 Similar to the able-bodied population, the longer survival with SCI has been accompanied by a higher prevalence of chronic disease and degenerative conditions in this population. 2, 3 The important causes of death in SCI patients have shifted from infectious diseases, renal failure and pneumonia 4 to cardiovascular disease and cancer, thus, approximating the causes of death seen in the able-bodied population. 5, 6 Recent studies have shown that cardiovascular diseases were the leading cause of death in persons with longstanding SCI (over 30 years) and among those with SCI age 60 and over. 7 Adults with SCI are at increased risk for cardiovascular morbidity, 8, 9 and mortality 5,7,10 compared with able-bodied population. There is also evidence to suggest that the prevalence of undetected asymptomatic coronary heart disease is higher in SCI individuals. Bauman et al 11 reported a 65% prevalence of silent cardiac ischemia on the basis of an abnormal arm exercise thallium scan in 20 asymptomatic subjects with paraplegia (mean age 53 years, mean duration of injury 17 years). Interestingly, electrocardiographic evidence of ischemia during arm exercise was present in only 25% of these subjects. Blocker et al 8 have also reported an increased prevalence of electrocardiographic ST-segment depression in 98 long-term survivors compared with the general population.
The increased prevalence of coronary heart disease in individuals with SCI is not explained by higher levels of several established cardiovascular disease risk factors such as blood pressure, cigarette smoking or total serum cholesterol (TC). 12 ± 14 One potential factor related to the increased risk for coronary heart disease in SCI may be a reduced level of high density lipoprotein cholesterol (HDL-C) in SCI subjects, which may, in part, be associated with a decreased level of physical activity in this group. There is considerable clinical and epidemiologic evidence for an association between the level of HDL-C or the ratio TC/HDL-C and cardiovascular disease risk in able-bodied populations. 15 ± 19 HDL-C less than 35 mg/dl (0.91 mmol/L) or TC/HDL-C ratio over 4.0 typically de®ne the risk threshold; however, the association between the level of HDL-C and cardiovascular disease risk is continuous, thus these cut points may be considered somewhat arbitrary. 25 Walker and Shephard 14 and Maki et al, 26 these studies compared HDL-C, TC, triglycerides (TG) and or TC/HDL-C ratio in samples of SCI individuals with able-bodied control groups. Subjects in these studies were predominantly men (total n=637 men, 71 women). Although the total number of SCI individuals evaluated over all studies is considerable, the sample size of individual studies is generally small and heterogeneous with respect to age, level of lesion, and duration of injury. Over half the reported studies involve less than 50 individuals with SCI. The duration of injury ranges from acute hospitalized patients 24, 27, 28 to persons living with SCI for over 18 years. 13, 25, 26, 29, 30 The age range of SCI subjects is also large (approximately 17 ± 71 years).
Despite the heterogeneity in samples both between and within studies, the results across studies are remarkably consistent. With the exception of the reports by Cardus et al 30 16 indicate approximately a 3.0 ± 3.5% increase in cardiovascular disease risk for each 1 mg/dl (0.026 mmol/L) decrease in HDL-C. Brenes et al, 24 using risk estimates developed from the Framingham data, estimated the mean level of HDL-C in their SCI subjects [34.8 mg/dl (0.90 mmol/L)] predicted an excess heart attack risk of 60%. Janssen et al, 31 also using Framingham risk data estimated an increased risk for cardiovascular disease of 18% in SCI subjects based on their level of HDL-C. These risk estimates for level of HDL-C in SCI individuals should be interpreted cautiously, as the importance of low HDL-C or the magnitude of the risk associated with low HDL-C in SCI individuals has not been established.
Total cholesterol
Total cholesterol is generally lower in SCI individuals compared with able-bodied controls. In the seven studies where SCI/able-bodied comparisons are reported, 3/7 (43%) show signi®cantly lower TC in the SCI subjects. In the four studies where nonsigni®cant dierences are reported the TC level of the SCI subjects was consistently lower than that of the ablebodied comparison group. The mean TC level in the studies reviewed was 186. with only 10% of able-bodied controls with both low TC and low HDL-C. Low levels of HDL-C are still a signi®cant risk factor for cardiovascular disease even in the presence of low TC. Data from the Physicians Health Study suggest that higher levels of HDL-C are more strongly associated with protection from cardiovascular disease among those with lower levels of TC. 17 Thus the ratio of TC/HDL-C has been shown to be a powerful predictor of cardiovascular disease risk. It is estimated that a change of 1 unit in this ratio is associated with a 53% increase in risk of myocardial infarction after adjustment for other risk factors. 17 
Total cholesterol/HDL-C
Five of the 12 studies reviewed provided data on TC/ HDL-C ratio. The mean TC/HDL-C ratio across the ®ve studies in healthy SCI subjects was 5.11 (range 4.6 ± 5.5). Only two studies presented TC/HDL-C ratios for both SCI subjects and able-bodied controls. 29, 32 Both reports found no signi®cant dierences between SCI and able-bodied controls, although the TC/HDL-C ratio was consistently higher in the SCI subjects. The results were similar for the remaining seven studies where the TC/HDL-C ratio could be calculated from the reported levels of TC and HDL-C (TC/HDL-C ratio mean=4.8, range 4.4 ± 5.5). In the studies reviewed the TC/HLD-C ratio in SCI individuals generally exceeded the risk level of 4.0, with the exception of a TC/HDL-C ratio (3.8) in six women with tetraplegia. 24 
Triglycerides
Six of the 12 studies included in Table 1 provided data on serum TG. Serum TG were signi®cantly higher in SCI compared with controls in two of the reports. 25, 28 In the four other studies TG tended to be higher in SCI than in controls, however the dierences were not statistically signi®cant. The mean TG level over the six studies included in Table 1 was 133 mg/dl (1.50 mmol/ L) in SCI compared with 111.4 mg/dl (1.26 mmol/L) in able-bodied controls. As will be discussed in more detail in a following section, elevated TG are often associated with reduced levels of HDL-C, both of which are associated with increased coronary heart disease risk.
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Limitations of available data
The available literature suggests decreased HDL-C, normal or low TC, and higher TG and high TC/HDL-C ratios in SCI individuals compared with able-bodied controls. However, these results need to be interpreted cautiously. The majority of the available evidence is for men. The data for women are based on three studies with a total n of 71. The reason for the observed dierences in HDL-C between able-bodied and individuals with SCI are unclear. There are a number of factors that signi®cantly eect HDL-C. For example, cigarette smoking, 36,37 beta blockers or diuretics, 38, 39 anti-spastic medication 38 decrease HDL-C, whereas moderate alcohol intake, 40, 41 and physical activity 42 increase HDL-C. Diet may also eect HDL-C level although published results are inconsistent. 43 ± 46 Bauman et al 47 have recently reported signi®cantly higher HDL-C in African-American compared with white or Latino men with chronic SCI. The studies presented in Table 1 have not adequately controlled for these potentially important confounders. Several studies have measured confounding factors; however, they have not used this information to adjust lipid values for comparisons between SCI and able-bodied samples. 13, 27, 31 Confounders need to be considered in future studies comparing SCI individuals with ablebodied controls to determine the magnitude of the dierence, if any, in HDL-C between these groups and to determine what factors may be associated with reduced HDL-C in this population. The next section describes a hypothetical model that oers a potential explanation for the reduced level of HDL-C in SCI and discusses the empirical evidence to support several of the hypothesized associations.
Biologic plausibility for lower HDL-C in SCI
SCI results in a constellation of changes including decreased physical activity, decreased lean and increased fat mass, and increased paralyzed muscle mass that individually, or in concert, may increase the probability for insulin resistance and hyperinsulinemia, which in turn may be associated with increased plasma triglycerides and decreased HDL-C. A model depicting these associations is presented in Figure 1 . There is empirical evidence to support several important aspects of these hypothesized associations.
Decreased physical activity
Although limited, the data on the physical activity level of individuals with SCI suggests they lead a sedentary lifestyle and avoid participation in vigorous physical activity to a greater extent than their able-bodied counterparts. Coyle and Kinney 48 in a survey of 790 adults with physical disabilities (23% SCI) showed that sedentary pursuits (reading, TV viewing, socializing, and art and music appreciation) comprised their favorite leisure time activities. Only 11% of the sample listed non-competitive sport as their favored leisure time pursuit. Dearwater et al 49 using an electronic motion sensor to monitor physical activity, found the level of activity in a sample of 28 men with SCI to be 30-fold lower than in similar aged, ablebodied college students.
A mail survey of 229 college graduates with locomotor disabilities (59 semi-ambulatory, 115 paraplegics, 55 tetraplegics) assessed physical activity on a 5-point scale in response to the question`When compared to other persons of your age your physical activity level is (1) much less than others to (5) much greater than others. Approximately 55% of the sample rated their current physical activity level as less or much less than their peers. 50 Decreased physical ®tness The negative eect of inactivity on cardiovascular ®tness is well documented in both able-bodied and SCI populations. 51, 52 Both cross sectional and longitudinal studies in individuals with SCI have demonstrated that peak oxygen uptake is higher in active compared to inactive groups and that peak oxygen uptake can be increased signi®cantly as result of endurance exercise training. 53,54 ± 57 It is estimated that approximately 25% of individuals with paraplegia, despite a relatively young age, show a peak oxygen uptake less than or equal to 15 ml/kg/min. 52 This level of cardiovascular ®tness is inadequate for a young adult and barely sucient to meet the demands of independent living. Low levels of cardiovascular ®tness are associated with increased risk for cardiovascular disease and total mortality in able-bodied individuals.
± 60
Changes in body composition Increased body fat is not only a risk factor for coronary heart disease through increased insulin resistance and hyperinsulinemia leading to non-insulin dependent diabetes mellitus (NIDDM), 61, 62 but is also associated with other chronic diseases such as cancer, 63 and hypertension. 64 Denervation and sedentary lifestyle associated with SCI result in increased fat and decreased lean tissue. Bauman et al 11 reported lean tissue to be 33% lower in a sample with SCI compared to ambulatory controls matched for age, gender, height and weight. They hypothesized that decreased lean tissue may be responsible for the increased insulin resistance often associated with SCI. Maki et al 26 reported signi®cant associations between central obesity, measured by abdominal circumference, and serum TG (r=0.59, P50.001), HDL-C (r=70.42, P50.01) and TC/HDL-C ratio (r=0.48, P50.01) in 43 men with SCI. Individuals with SCI are prone to the development of obesity. Resting metabolic rate is 10 ± 30% lower in SCI compared with able-bodied persons of comparable age 65 with metabolic rate inversely Figure 1 Hypothetical model: The eect of spinal cord injury on physical activity, high density lipoprotein cholesterol and cardiovascular disease risk associated with level of lesion. 66 The lower resting metabolic rate and the limited muscle mass available to increase metabolism during exercise make it dicult for individuals with SCI to control weight.
Insulin resistance and hyperinsulinemia
Several investigators have reported a high prevalence of impaired glucose tolerance among individuals with long-standing SCI.
11,67 ± 69 For example, Bauman and Spungen 11 found 22% of 100 SCI men (50 paraplegic, 50 tetraplegic) were diabetic based on results of an oral glucose tolerance test, compared with only 6% of agematched, able-bodied controls. They noted that the results of glucose tolerance tests were normal in 82% of control subjects compared with 38% of subjects with tetraplegia and 50% of subjects with paraplegia. Bauman 70 provides an excellent review on carbohydrate and lipid metabolism in individuals after SCI.
Poor glucose tolerance in SCI is characterized by elevated levels of plasma insulin, suggesting an increase in insulin resistance. 11, 68 Both poor glucose tolerance and high insulin levels have been associated with increased cardiovascular disease risk. 71 ± 73 High levels of plasma insulin have been associated with decreased HDL-C, possibly through an increase in plasma TG. 29,69,74 ± 76 An association between elevated insulin and elevated TG has been demonstrated in individuals with SCI. For example, Zhong et al 69 have shown signi®cantly higher TG in a subgroup of 197 SCI individuals, mean age 50 years, mean duration of injury 18 years, who were hyperinsulinemic compared with a subgroup with normal insulin levels. Increased levels of TG have also been associated with reduced HDL-C in both SCI and able-bodied samples. Bauman et al 29 showed a signi®cant inverse association between serum TG and HDL-C in SCI individuals (50 paraplegic, 50 tetraplegic) and in able-bodied controls. In a subgroup of 12 paraplegics, Bauman et al 29 also reported a signi®cant positive correlation between insulin sensitivity and HDL-C. Laakso et al 74 reported that able-bodied subjects who were insulin resistant had higher TG and lower HDL-C than subjects with normal glucose tolerance. Signi®cant inverse correlations between serum TG and HDL-C in both SCI and able-bodied subjects (r=70.41 ± r=70.67) have also been reported by several other investigators. 31, 33, 41 However, Bauman et al 29 failed to detect signi®cant dierences in HDL-C in SCI subjects who were classi®ed as normal, impaired, or diabetic based on an oral glucose tolerance test.
A key unanswered question is why does insulin resistance develop in individuals with SCI? As mentioned previously, denervation of skeletal muscle, changes in body composition (decreased lean and increased fat mass), and reductions in physical activity associated with SCI may all play a role in increasing insulin resistance. Duckworth et al 67 have shown that an insulin resistant group of SCI patients was signi®cantly heavier than SCI patients with normal insulin sensitivity even though their level of body mass index was not such to be classi®ed as obese. Bauman and Spungen 11 using body composition measured by dual energy X-ray absorptiometry (DEXA), found the average per cent fat in SCI subjects to be approximately 30%; however, unlike reports in able-bodied subjects, adiposity was not a signi®cant determinant of insulin sensitivity. 77 Additional reports have shown decreased insulin sensitivity associated with increased body fat in healthy able-bodied subjects 78 ± 80 and ablebodied subjects with NIDDM. 81 It is possible that factors other than increased body fat are important determinants of insulin sensitivity in SCI, or perhaps the currently available measures of body composition do not provide accurate estimates of body fat in individuals with SCI. 82 Decreased muscle mass associated with SCI may play a role in the insulin resistance observed in this group 83, 84 considering that skeletal muscle is a major site of glucose uptake. In addition, paralyzed muscle associated with SCI may also aect insulin resistance. Both in vivo and in vitro animal studies have suggested impaired glucose uptake and insulin resistance in denervated muscle. 85, 86 Reduced physical activity also plays an important role in impaired glucose tolerance and hyperinsulinemia. 87, 88 Minimal amounts of physical activity have been shown to improve glucose tolerance. 89 Exercise training decreases insulin secretion in both the basal state and in response to a carbohydrate load. 90 ± 92 However, Duckworth et al 67 did not ®nd an association between level of physical activity and insulin sensitivity in SCI subjects. Increased cardiovascular ®tness has also been associated with increased insulin sensitivity. 93 Bauman and Spungen 11 reported that peak oxygen uptake measured during arm ergometry was the strongest determinant of peripheral insulin sensitivity in 12 individuals with paraplegia.
It appears that a reduction in physical activity in SCI, which favors decreased cardiovascular ®tness, increased fat mass and decreased lean mass may play a pivotal role in the apparent reduction in HDL-C observed in this group. However, the data on the association between either physical activity or cardiovascular ®tness and HDL-C in individuals with SCI is limited. In the following section we review the literature regarding the association of both physical activity and cardiovascular ®tness and HDL-C in individuals with SCI.
Physical activity and HDL
Numerous cross-sectional and longitudinal studies in able-bodied individuals have reported a favorable eect of increased physical activity on HDL-C. 42 However, there is considerable controversy regarding the amount and intensity of physical activity required to elicit this eect. 94 Several studies have suggested that vigorous exercise training programs, ie, running, stair climbing etc. greater than 75% maximal heart rate or greater than 7 kcal/min are necessary to elicit signi®cant increases in HDL-C 45,95 ± 97 while other reports suggest that HDL-C can be signi®cantly increased by low to moderate intensity exercise training.
98 ± 101 A recent report by Crouse et al 102 suggests that changes in blood lipids in hypercholesterolemic men are not in¯uenced by exercise intensity when the caloric expenditure of the exercise programs are held constant. In contrast to an extensive literature on HDL-C and physical activity in able-bodied samples the literature regarding the eect of physical activity on HDL-C in SCI subjects is limited to four cross-sectional studies of physical activity and HDL-C, 13, 24, 31, 103 three reports on the cross-sectional association between cardiovascular ®tness and HDL-C 29,31,104 and one exercise training study. 105 Cross-sectional studies of physical activity
Results from two studies which report SCI athlete/nonathletes comparisons for HDL-C, TC and TG are presented in Table 2 . 24, 103 In the Brenes et al 24 report athletes were involved in an aerobic exercise program a minimum of 3 days per week and participated in the following sports: 12 track and ®eld, ®ve swimming, three weight training, and two road racing. Dallmeijer et al 103 de®ned active participants as those who had engaged in regular sport activities for at least 6 months. Results of both studies showed signi®cantly higher HDL-C in active compared with sedentary men. Triglyceride levels did not dier signi®cantly between male athletes and sedentary controls in either study. Brenes et al 24 reported signi®cantly lower TC in athletes compared with controls, while no signi®cant dierences in TC were noted between activity groups by Dallmeijer et al. 103 The dierences in TC and HDL-C between male SCI athletes and SCI controls reported by Brenes et al 24 persisted after control for body mass index, cigarette smoking and alcohol consumption. It is interesting to note that the mean HDL-C in the male SCI athletes [42.7 mg/dl (1.10 mmol/L)] in the Brenes study, while higher than sedentary SCI controls, was still lower than that reported for the sedentary able-bodied control group [46 mg/dl (1.19 mmol/)], although the difference was not statistically signi®cant. 24 This suggests that in some individuals the amount of training associated with participation in wheelchair sports may not be of sucient intensity or duration to increase HDL-C in persons with SCI to the levels typically observed in able-bodied samples. Multiple regression analysis reported by Dallmeijer et al 103 indicated that sport participation was the only signi®cant independent predictor of HDL-C while both age and time since injury were signi®cant predictors of TG.
Additional evidence for an association between physical activity and HDL-C in SCI is available in the reports of Krum et al 13 and Janssen et al. 31 Krum et al 13 assessed physical activity on an ordinal 5-point scale (0=no exercise to 4 wheelchair athlete) in 102 SCI patients, ages 25 ± 64 years. Results showed a non-signi®cant positive association between HDL-C and reported exercise (r=0.54, P=0.086). Janssen et al 31 also reported no significant association between the frequency of physical activity (number of hours per week of active sport participation) and HDL-C. Cross-sectional studies ± cardiovascular ®tness Bostom 104 assessed the association between cardiovascular ®tness assessed by maximal arm ergometry and HDL-C in nine men with SCI (T5 ± T12), mean age 31 years, at least 4 years post-injury (average injury duration=13.7 years) who lived independently in the community. The mean HDL-C in this sample, 46+8 mg/dl (1.19+0.21 mmol/L), is higher than that reported in any group of SCI men included in Table 1 . The authors speculate that the higher level of HDL-C in this sample may be due to a higher level of physical activity. This speculation is supported by their ®nding of a peak oxygen uptake of 29.1+3.6 ml/kg/min which is higher than that reported for sedentary subjects with paraplegia 31, 106 but less than that reported in wheelchair racers. 107 The arm ergometry peak oxygen uptake was not signi®cantly associated with either HDL-C (r=0.47) or TC (r=70.51), but was signi®cantly associated with a reduced TC/HDL-C ratio (r=70.86, P50.01) and TG (r=70.73, P50.05). Inadequate statistical power most likely explains the lack of statistical signi®cance in the association of HDL-C and TC with cardiovascular ®tness. Janssen et al 31 found no signi®cant association between peak oxygen uptake, assessed by wheelchair ergometry, and HDL-C (r=0.16) or TG (r=70.10) in 37 SCI men. However, peak oxygen uptake was signi®cantly associated with TC/HDL-C ratio (r=70.35, P50.05). Bauman et al 29 in a subgroup of 12 subjects with paraplegia (total n=50) reported a nonsigni®cant direct association between HDL-C and cardiovascular ®tness determined by arm crank ergometry; however, the magnitude of the correlation was not provided.
Exercise training studies
Hooker and Wells 105 reported on eight SCI individuals (four men, four women) who participated in two dierent supervised 8-week wheelchair ergometer exercise training programs, 20 min per session, three times per week. The training programs diered by intensity: low (50% to 60% heart rate reserve) and moderate (70% to 80% heart rate reserve). Results showed no dierence in peak aerobic capacity or peak power output as a result of training. There were no signi®cant changes in TC, TG or HDL-C in the low intensity group. In the moderate intensity group HDL-C increased from 39 ± 47 mg/dl [1.0 ± 1.22 mmol/L] (P50.10), TC/HDL-C ratio decreased from 5 to 4 (P50.10) and TG decreased from 96 to 78 mg/dl [1.08 to 0.88 mmol/L)] (P50.01). These results are suggestive of a favorable eect of supervised wheelchair ergometer training on HDL-C in SCI individuals, however, this study involved a very small number of subjects who were not randomly assigned to treatment and involved no control group. In addition, the study sample was heterogeneous regarding level of lesion, duration of injury and gender and there was no control for diet, cigarette smoking, or alcohol consumption.
Other evidence for a physical activity/HDL-C association
The level of lesion may serve as a surrogate measure for participation in physical activity. A higher level of physical activity and higher HDL-C might be expected in subjects with paraplegic compared to those with tetraplegia. However, the results of several studies that have evaluated HDL-C in both these groups have not supported this hypothesis. 13,24,29 ± 31 The ®nding of no dierence in HDL-C by lesion level may be associated with both behavioral and physiologic dierences between the groups. This is exempli®ed in the report of 
Summary and recommendations
The limited available data suggest a potential important role for physical activity to increase the level of HDL-C in SCI subjects, possibly as a result of decreased body fat, increased insulin sensitivity or increased cardiovascular ®tness and associated metabolic changes, any and all of which may be associated with decreased cardiovascular disease risk. The available information on physical activity and HDL-SC in SCI subjects comes from studies that have used imprecise measures of physical activity including athlete/non-athlete comparisons, 24 semiquantitative rating scales 13 or reported hours per week of active sport participation. 31 Additional studies using more precise physical activity measures that are developed and validated in SCI subjects are needed to provide further insight into exercise parameters associated with HDL-C in this population. The eect of physical activity on HDL-C in SCI should be further investigated with both crosssectional studies of SCI subjects over a complete range of physical activity levels and with longitudinal training studies of variable frequency, intensity, duration and mode. In both cross-sectional and longitudinal studies it will be important to assess and adequately control for important confounders and obtain samples of sucient size to minimize the heterogeneity inherent in samples with SCI. It will be important to determine if individuals with SCI, given the reduction in active muscle mass, can exercise at an intensity and duration sucient to increase HDL-C. From a practical perspective it would be useful to know if individuals with SCI are capable of increasing their daily physical activity, apart from structured exercise programs, to a level that will signi®cantly aect HDL-C.
Finally, studies should be undertaken to further elucidate the mechanism of altered lipid metabolism in SCI. Do the observed alterations in HDL-C result from metabolic dysregulation inherent in SCI or are they more strongly associated with behavioral factors such as smoking, alcohol consumption, diet or physical inactivity? Knowledge of the mechanism for any reduction in HDL-C in individuals with SCI may provide insight into the design of behavioral interventions to decrease cardiovascular disease risk in this group.
